2,860
Views
2
CrossRef citations to date
0
Altmetric
Articles

Immunoglobulin D (IgD) and IgD receptor expression in diffuse large B-cell lymphoma

, , , , , & show all

References

  • Sun F, Zhu J, Lu S, et al. An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era. BMC Cancer. 2018;18(1):5.
  • Chiappella A, Santambrogio E, Castellino A, et al. Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma. Expert Rev Hematol. 2017;10(8):697–705.
  • Kerr WG, Hendershot LM, Burrows PD. Regulation of IgM and IgD expression in human B-lineage cells. J Immunol. 1991;146(10):3314–3321.
  • Untanu RV, Back J, Appel B, et al. Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: a report from the Children’s Oncology group. Pediatr Blood Cancer. 2018;65(1):e26753.
  • Haerzschel A, Catusse J, Hutterer E, et al. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia. Ann Hematol. 2016;95(12):1979–1988.
  • Ishii K, Yamato K, Kubonishi I, et al. IgD myeloma presenting as a testicular tumor: establishment and characterization of an IgD-secreting myeloma cell line. Am J Hematol. 1992;41(3):218–224.
  • Gobbi PG, Merlini G, Lattanzio G, et al. Serum IgD in Hodgkin’s disease. Acta Haematol. 1981;66(1):35–38.
  • Carey GB, Scott DW. Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas. J Immunol. 2001;166(3):1618–1626.
  • Tavolaro S, Peragine N, Chiaretti S, et al. Igd cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells. Leuk Res. 2013;37(4):455–462.
  • Lakshmi TSM, Wu Y, Toporovsky I, et al. Igd receptor-mediated signal transduction in T cells. Cell Immunol. 2001;207(2):110–117.
  • Coico RF, Tamma SL, Bessler M, et al. IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. J Immunol. 1990;145(11):3556–3561.
  • Coico RF, Siskind GW, Thorbecke GJ. Role of IgD and T delta cells in the regulation of the humoral immune response. Immunol Rev. 1988;105:45–68.
  • Rudders RA, Andersen J. IgD-Fc receptors on normal and neoplastic human B lymphocytes. Clin Exp Immunol. 1982;50(3):579–586.
  • Chen K, Cerutti A. New insights into the enigma of immunoglobulin D. Immunol Rev. 2010;237(1):160–179.
  • Wu Y, Chen W, Chen H, et al. The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis. PLoS One. 2016;11(1):e0147788.
  • Chen K, Xu W, Wilson M, et al. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol. 2009;10(8):889–898.
  • Wu YJ, Chen HS, Chen WS, et al. CP-25 attenuates the activation of CD4+T cells stimulated with immunoglobulin D in human. Front Pharmacol. 2018;9:4.
  • Wu YJ, Chen WS, Chen HS, et al. The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation. Acta Pharmacol Sin. 2017;38(11):1466–1474.
  • Dai X, Wu Y, Jia X, et al. hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity. Immunol Res. 2016;64(4):978–987.
  • Koch K, Klapper W. Classification of malignant lymphomas. Internist (Berl). 2016;57(3):206–213.
  • Lisanti MP, Sargiacomo M. Biotinylation and analysis of membrane-bound and soluble proteins. Curr Protoc Immunol. 2001; Chapter 8: Unit 8.16.
  • Choi CH, Park YH, Lim JH, et al. Prognostic implication of semi-quantitative immunohistochemical assessment of CD20 expression in diffuse large B-cell lymphoma. J Pathol Transl Med. 2016;50(2):96–103.
  • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282.
  • Rigante D. The truth on IgD in the ploy of immune surveillance and inflammation. Immunol Res. 2016;64(2):632–635.
  • Papadaki T, Stamatopoulos K, Mavrommatis T, et al. A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: ontogenetic implications. Leuk Res. 2008;32(1):155–157.
  • Nguyen TG, Little CB, Yenson VM, et al. Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance. J Autoimmun. 2010;35(1):86–97.
  • Goding JW. Allotypes of IgM and IgD receptors in the mouse: a probe for lymphocyte differentiation. Contemp Top Immunobiol. 1978;8:203–243.
  • Jelinek DF, Splawski JB, Lipsky PE. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets. J Immunol. 1986;136(1):83–92.
  • Zheng Y, Zhou X, Xie J, et al. Igm expression in paraffin sections distinguishes follicular lymphoma from reactive follicular hyperplasia. Int J Clin Exp Pathol. 2014;7(6):3264–3271.
  • Zettl A, Meister S, Katzenberger T, et al. Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas. Histopathology. 2003;43(3):209–219.
  • Papadaki T, Stamatopoulos K, Belessi C, et al. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases. Am J Surg Pathol. 2007;31(3):438–446.
  • Coico RF, Xue B, Wallace D, et al. T cells with receptors for IgD. Nature. 1985;316(6030):744–746.
  • Wu Y, Lakshmi TSM, Lima V, et al. Facilitated antigen presentation by B cells expressing IgD when responding T cells express IgD-receptors. Cell Immunol. 1999;192(2):194–202.
  • Sokoya M, Ramakrishnan VR, Frank DN, et al. Expression of immunoglobulin D is increased in chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2017;119(4):317–323.e1.
  • Abadi U, Peled L, Gurion R, et al. Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma. Leuk Lymphoma. 2019: 1–5.
  • Chen W, Luo RC, Fan WW, et al. Clinical value of combined detection of LDH, TPS, CEA and beta2-MG in patients with non-Hodgkin’s lymphoma. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(2):227–228. 230.
  • Park JH, Yoon DH, Kim DY, et al. The highest prognostic impact of LDH among international prognostic indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab. Ann Hematol. 2014;93(10):1755–1764.
  • Biccler J, Eloranta S, de Nully Brown P, et al. Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI. Cancer Med. 2018;7(1):114–122.